| Financial Year |
March 31 2023 |
| Monetary Funds |
745,342,053.29 |
| Held-for-trading Financial Assets |
2,473,102.00 |
| Notes Receivable |
847,314,585.54 |
| Accounts Receivable |
1,419,949,898.38 |
| Advances to Suppliers |
139,809,554.06 |
| Other Receivables |
304,398,441.38 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
796,429,037.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
128,706,771.10 |
| Other Current Assets |
115,271,605.53 |
| Total Current Assets |
4,622,261,832.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
227,704,511.11 |
| Long-term Equity Investment |
491,719,342.66 |
| Investment Properties |
232,175,979.68 |
| Fixed Assetes |
2,703,921,003.21 |
| Under-construction Projects |
394,324,013.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
507,374,788.22 |
| R&D expenses |
32,280,097.47 |
| Goodwill |
256,504,945.02 |
| Long-Term Deferred and Prepaid Expenses |
8,981,541.99 |
| Deferred Income Tax Assets |
138,837,990.10 |
| Other Non-Current Assets |
371,711,194.29 |
| Sub-Total of Non-Current Assets |
5,511,716,028.60 |
| Total Assets |
10,133,977,861.20 |
| Short-Term Loans |
1,250,178,750.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,265,176,469.67 |
| Accounts Payable |
1,232,623,130.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,115,839.38 |
| Taxes Payable |
55,119,987.28 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
14,414,049.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,416,959.23 |
| Other Current Liabilities |
279,557.52 |
| Sub-Total of Current Liabilities |
3,878,205,229.49 |
| Long-term Loans |
200,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
37,924,460.95 |
| Special Payable |
-- |
| Estimatied Liabilities |
55,349,425.58 |
| Deferred Income Tax Liabilities |
6,021,985.43 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
523,386,660.60 |
| Total Liabilities |
4,401,591,890.09 |
| Paid-In Capital(Or Share Stock) |
1,312,600,000.00 |
| Capital Surplus |
2,840,834,667.33 |
| Surplus Reserve |
290,753,248.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,280,784,488.88 |
| Minority Stockholder's Interest |
7,413,566.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,724,972,404.66 |
| Owner's Equity（Stockholder's Equity） |
5,732,385,971.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,133,977,861.20 |
